Dexmedetomidine regulates exosomal miR-29b-3p from macrophages and alleviates septic myocardial injury by promoting autophagy in cardiomyocytes via targeting glycogen synthase kinase 3β

Abstract

Background: Our previous research suggested that dexmedetomidine (Dex) promotes autophagy in cardiomyocytes, thus safeguarding them against apoptosis during sepsis. However, the underlying mechanisms of Dex-regulated autophagy have remained elusive. This study aimed to explore the role of exosomes and how they participate in Dex-induced cardioprotection in sepsis. The underlying microRNA (miRNA) mechanisms and possible therapeutic targets for septic myocardial injury were identified. Methods: We first collected plasma exosomes from rats with sepsis induced by caecal ligation and puncture (CLP) with or without Dex treatment, and then incubated them with H9c2 cells to observe the effect on cardiomyocytes. Subsequently, the differential expression of miRNAs in plasma exosomes from each group of rats was identified through miRNA sequencing. miR-29b-3p expression in circulating exosomes of septic or non-septic patients, as well as in lipopolysaccharide-induced macrophages after Dex treatment, was analysed by quantitative real-time polymerase chain reaction (qRT–PCR). The autophagy level of cardiomyocytes after macrophage-derived exosome treatment was assessed by an exosome tracing assay, western blotting, and an autophagic flux assay. Specific miRNA mimics and inhibitors or small interfering RNAs were used to predict and evaluate the function of candidate miRNA and its target genes by qRT-PCR, annexin V/propyl iodide staining, autophagy flux analysis, and western blotting. Results: We found that plasma-derived exosomes from Dex-treated rats promoted cardiomyocyte autophagy and exerted antiapoptotic effects. Additionally, they exhibited a high expression of miRNA, including miR-29b-3p. Conversely, a significant decrease in miR-29b-3p was observed in circulating exosomes from CLP rats, as well as in plasma exosomes from sepsis patients. Furthermore, Dex upregulated the lipopolysaccharide-induced decrease in miR-29b-3p expression in macrophage-derived exosomes. Exosomal miR-29b-3p from macrophages is thought to be transferred to cardiomyocytes, thus leading to the promotion of autophagy in cardiomyocytes. Database predictions, luciferase reporter assays, and small interfering RNA intervention confirmed that glycogen synthase kinase 3β (GSK-3β) is a target of miR-29b-3p. miR-29b-3p promotes cardiomyocyte autophagy by inhibiting GSK-3β expression and activation. Conclusions: These findings demonstrate that Dex attenuates sepsis-associated myocardial injury by modulating exosome-mediated macrophage–cardiomyocyte crosstalk and that the miR-29b-3p/GSK-3β signaling pathway represents a hopeful target for the treatment of septic myocardial injury.

Keywords

Exosome / miR-29b-3p / Dexmedetomidine / Sepsis / Cardiomyocytes / Macrophages / Autophagy / Apoptosis / Glycogen synthase kinase 3β

References

[1] Pomara C, Riezzo I, Bello S, de Carlo D, Neri M, Turillazzi E. A pathophysiological insight into sepsis and its correlation with Postmortem diagnosis. Mediat Inflamm 2016; 2016: 1-11. https://doi.org/10.1155/2016/4062829.

[2] Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol 2021; 18: 424-34. https://doi.org/10.1038/s41569-020-00492-2.

[3] Chen X, Liu Y, Gao Y, Shou S, Chai Y. The roles of macrophage polarization in the host immune response to sepsis. Int Immunopharmacol 2021; 96: 107791. https://doi.org/10.1016/j.intimp.2021.107791.

[4] Zaman R, Epelman S. Resident cardiac macrophages: heterogeneity and function in health and disease. Immunity 2022; 55: 1549-63. https://doi.org/10.1016/j.immuni.2022.08.009.

[5] Park EJ, Appiah MG, Myint PK, Gaowa A, Kawamoto E, Shimaoka M. Exosomes in sepsis and inflammatory tissue injury. Curr Pharm Des 2019; 25: 4486-95. https://doi.org/10.2174/1381612825666191116125525.

[6] Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab 2021; 33: 1744-62. https://doi.org/10.1016/j.cmet.2021.08.006.

[7] Fadaei S, Zarepour F, Parvaresh M, Motamedzadeh A, Tamehri Zadeh SS, Sheida A, et al. Epigenetic regulation in myocardial infarction: non-coding RNAs and exosomal non-coding RNAs. Front Cardiovasc Med 2022; 9: 1014961. https://doi.org/10.3389/fcvm.2022.1014961.

[8] de Couto G, Gallet R, Cambier L, Jaghatspanyan E, Makkar N, Dawkins JF, et al. Exosomal MicroRNA transfer into macrophages mediates cellular Postconditioning. Circulation 2017; 136: 200-14. https://doi.org/10.1161/CIRCULATIONAHA.116.024590.

[9] Zhang G, Dong D, Wan X, Zhang Y. Cardiomyocyte death in sepsis: mechanisms and regulation (review). Mol Med Rep 2022; 26: 257. https://doi.org/10.3892/mmr.2022.12773.

[10] Liu CY, Zhang YH, Li RB, Zhou LY, An T, Zhang RC, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun 2018; 9: 29. https://doi.org/10.1038/s41467-017-02280-y.

[11] Xing Y, Sui Z, Liu Y, Wang MM, Wei X, Lu Q, et al. Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy. Basic Res Cardiol 2022; 117: 20. https://doi.org/10.1007/s00395-022-00930-x.

[12] Yan L, Sadoshima J, Vatner DE, Vatner SF. Autophagy: a novel protective mechanism in chronic ischemia. Cell Cycle 2006; 5: 1175-7. https://doi.org/10.4161/cc.5.11.2787.

[13] Yu T, Liu D, Gao M, Yang P, Zhang M, Song F, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of alpha7nAChR and PI3K/Akt-mediated autophagy. Biomed Pharmacother 2019; 120: 109231. https://doi.org/10.1016/j.biopha.2019.109231.

[14] Gao M, Yu T, Liu D, Shi Y, Yang P, Zhang J, et al. Sepsis plasma-derived exosomal miR-1-3p induces endothelial cell dysfunction by targeting SERP1. Clin Sci (Lond) 2021; 135: 347-65. https://doi.org/10.1042/CS20200573.

[15] Alverdy JC, Keskey R, Thewissen R. Can the Cecal ligation and puncture model Be repurposed to better inform therapy in human sepsis? Infect Immun 2020; 88: e00942-19. https://doi.org/10.1128/IAI.00942-19.

[16] Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 2019; 8: 727. https://doi.org/10.3390/cells8070727.

[17] Ivanov VV, Buyko EE, Ufandeev AA, Nevskaya KV, Udut EV, Poluektova KI, et al. Intracellular lipid levels and oxidative stress in peripheral blood mononuclear cells in experimental type 1 diabetes mellitus. Bull Exp Biol Med 2023; 174: 719-22. https://doi.org/10.1007/s10517-023-05778-2.

[18] Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol 2008; 445: 77-88. https://doi.org/10.1007/978-1-59745-157-4_4.

[19] Tran S, Fairlie WD, Lee EF. BECLIN1: protein structure, function and regulation. Cells 2021; 10: 1522. https://doi.org/10.3390/cells10061522.

[20] Jeong SJ, Zhang X, Rodriguez-Velez A, Evans TD, Razani B. p62/SQSTM1 and selective autophagy in Cardiometabolic diseases. Antioxid Redox Signal 2019; 31: 458-71. https://doi.org/10.1089/ars.2018.7649.

[21] Qin Y, Long L, Huang Q. Extracellular vesicles in toxicological studies: key roles in communication between environmental stress and adverse outcomes. J Appl Toxicol 2020; 40: 1166-82. https://doi.org/10.1002/jat.3963.

[22] Arishe OO, Priviero F, Wilczynski SA, Webb RC. Exosomes as intercellular messengers in hypertension. Int J Mol Sci 2021; 22: 11685. https://doi.org/10.3390/ijms222111685.

[23] Zhang K, Wang Y, Chen S, Mao J, Jin Y, Ye H, et al. TREM2(hi) resident macrophages protect the septic heart by maintaining cardiomyocyte homeostasis. Nat Metab 2023; 5: 129-46. https://doi.org/10.1038/s42255-022-00715-5.

[24] Chen XS, Wang SH, Liu CY, Gao YL, Meng XL, Wei W, et al. Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-kappaB and MAPK signaling. Pharmacol Res 2022; 185: 106473. https://doi.org/10.1016/j.phrs.2022.106473.

[25] Chen Z, Wu H, Fan W, Zhang J, Yao Y, Su W, et al. Naringenin suppresses BEAS-2B-derived extracellular vesicular cargoes disorder caused by cigarette smoke extract thereby inhibiting M1 macrophage polarization. Front Immunol 2022; 13: 930476. https://doi.org/10.3389/fimmu.2022.930476.

[26] Lin J, Song T, Li C, Mao W. GSK-3beta in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118659. https://doi.org/10.1016/j.bbamcr.2020.118659.

[27] Sharma AK, Bhatia S, Al-Harrasi A, Nandave M, Hagar H. Crosstalk between GSK-3beta-actuated molecular cascades and myocardial physiology. Heart Fail Rev 2021; 26: 1495-504. https://doi.org/10.1007/s10741-020-09961-9.

[28] Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 2001; 9: 1143-52. https://doi.org/10.1016/S0969-2126(01)00679-7.

[29] Murai H, Okazaki M, Kikuchi A.Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett 1996; 392: 153-60. https://doi.org/10.1016/0014-5793(96)00806-X.

[30] Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, et al. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem 2010; 285: 41122-34. https://doi.org/10.1074/jbc.M110.130351.

[31] Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009; 108: 1841-7. https://doi.org/10.1213/ane.0b013e318195e11d.

[32] Qi B, He L, Zhao Y, Zhang L, He Y, Li J, et al. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis. Diabetologia 2020; 63: 1072-87. https://doi.org/10.1007/s00125-020-05103-w.

[33] Ma T, Huang X, Zheng H, Huang G, Li W, Liu X, et al. SFRP2 improves mitochondrial dynamics and mitochondrial biogenesis, oxidative stress, and apoptosis in diabetic cardiomyopathy. Oxidative Med Cell Longev 2021; 2021: 9265016. https://doi.org/10.1155/2021/9265016.

[34] Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 2005; 106: 147-62. https://doi.org/10.1016/j.pharmthera.2004.11.006.

[35] Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in cardiovascular disease. Circ Res 2017; 120: 1812-24. https://doi.org/10.1161/CIRCRESAHA.117.311082.

[36] Ikeda S, Zablocki D, Sadoshima J. The role of autophagy in death of cardiomyocytes. J Mol Cell Cardiol 2022; 165: 1-8. https://doi.org/10.1016/j.yjmcc.2021.12.006.

[37] Wu X, Liu Z, Yu XY, Xu S, Luo J. Autophagy and cardiac diseases: therapeutic potential of natural products. Med Res Rev 2021; 41: 314-41. https://doi.org/10.1002/med.21733.

[38] Bao N, Tang B. Organ-protective effects and the underlying mechanism of Dexmedetomidine. Mediat Inflamm 2020; 2020: 6136105. https://doi.org/10.1155/2020/6136105.

[39] Aidoni Z, Pourzitaki C, Stamoula E, Kotzampassi K, Tsaousi G, Kazakos G, et al. Circulatory effects of dexmedetomidine in early sepsis: a randomised controlled experimental study. Naunyn Schmiedeberg’s Arch Pharmacol 2020; 393: 89-97. https://doi.org/10.1007/s00210-019-01713-3.

[40] Tang X, Zhang C, Tian T, Dai X, Xing Y, Wang Y, et al. Posttreatment with dexmedetomidine aggravates LPS-induced myocardial dysfunction partly via activating cardiac endothelial alpha(2A)-AR in mice. Int Immunopharmacol 2023; 116: 109724. https://doi.org/10.1016/j.intimp.2023.109724.

[41] Chen Q, Qin Z, Sun Y, Liu X, Pac Soo A, Chang E, et al. Dexmedetomidine activates Akt, STAT6 and IRF4 modulating Cytoprotection and macrophage anti-inflammatory phenotype against acute lung injury in vivo and in vitro. J Inflamm Res 2022; 15: 2707-20. https://doi.org/10.2147/JIR.S357012.

[42] Zhou H, Sun J, Zhong W, Pan X, Liu C, Cheng F, et al. Dexmedetomidine preconditioning alleviated murine liver ischemia and reperfusion injury by promoting macrophage M2 activation via PPARgamma/STAT3 signaling. Int Immunopharmacol 2020; 82: 106363. https://doi.org/10.1016/j.intimp.2020.106363.

[43] Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, Zanc V, et al. Multiplex cytokine profiling in patients with sepsis. APMIS 2011; 119: 155-63. https://doi.org/10.1111/j.1600-0463.2010.02705.x.

[44] Raeven P, Zipperle J, Drechsler S. Extracellular vesicles as markers and mediators in sepsis. Theranostics 2018; 8: 3348-65. https://doi.org/10.7150/thno.23453.

[45] Maiese A, Scatena A, Costantino A, Chiti E, Occhipinti C, La Russa R, et al. Expression of MicroRNAs in sepsis-related organ dysfunction: a systematic review. Int J Mol Sci 2022; 23: 9354. https://doi.org/10.3390/ijms23169354.

[46] Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release 2022; 347: 533-43. https://doi.org/10.1016/j.jconrel.2022.05.027.

[47] He D, Yan L. MiR-29b-3p aggravates cardiac hypoxia/reoxygenation injury via targeting PTX3. Cytotechnology 2021; 73: 91-100. https://doi.org/10.1007/s10616-020-00446-z.

[48] Li Z, Yi N, Chen R, Meng Y, Wang Y, Liu H, et al. miR-29b-3p protects cardiomyocytes against endotoxin-induced apoptosis and inflammatory response through targeting FOXO3A. Cell Signal 2020; 74: 109716. https://doi.org/10.1016/j.cellsig.2020.109716.

[49] Yang Q, Wu F, Mi Y, Wang F, Cai K, Yang X, et al. Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2. Cell Prolif 2020; 53: e12764. https://doi.org/10.1111/cpr.12764.

[50] Zhang Y, Fan X, Su Z, Yuan T, Yin H, Gu H, et al. Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3beta activation. Environ Toxicol 2021; 36: 2414-25. https://doi.org/10.1002/tox.23354.